1. Radiotherapy can play roles in both curative and palliative settings for the management of hepatocellular carcinoma (HCC). 2. For small HCC lesions within Milan criteria, stereotactic ablative radiotherapy delivers a high radiation dose in 1-4 fractions and can be used for tumors that are unresectable or ineligible for other local therapies. 3. For larger HCC lesions, radiotherapy can be combined with transarterial chemoembolization to consolidate treatment or salvage refractory lesions after repeated TACE. This combines the effects of radiation and prolonged exposure to chemoagents from TACE. 4. Radiotherapy may also help control vascular